In an unexpected turn of events, the midcap segment of the Indian stock market witnessed a significant rally in FY24, with certain stocks outperforming their peers and the broader market. Notably, Trent, Aurobindo Pharma, Lupin, and Solar Industries emerged as the triumphant ‘tortoises,’ showcasing remarkable resilience and growth amidst volatile market conditions. These stocks have not only doubled in value but have also demonstrated a low beta, indicating lower volatility compared to the benchmark Sensex.
Consistent Performers Lead the Pack
The journey through FY24 for these standout stocks was marked by consistent performance. Unlike the rapid fluctuations seen in their counterparts, these four stocks maintained a steady climb throughout the year. This was particularly notable in the case of Solar Industries, which, despite a brief 5% decline, quickly rebounded. Financial analyses reveal that all four companies have shown significant growth in net profits and operating margins, cementing their positions as leaders in their respective sectors.
Analysts Bullish on Future Prospects
Market analysts have expressed optimism about the future of these stocks. Aurobindo Pharma, for instance, saw a substantial increase in its net profit and operating profit margins, leading to a ‘buy’ rating from Axis Direct. Similarly, Trent’s aggressive expansion and improved revenue productivity have earned it a favorable outlook from Motilal Oswal. Lupin and <a href=”https://www.moneycontrol.com/news/business/markets/of-myths-and-midcaps-four-tortoise-stocks-that-won-the-race-in-2024-12567
-
Previous Post
Dollar reaches another historic peak